Gelonghui November 11th | shanxi c&y pharmaceutical group (300254.SZ) stated on the investor interaction platform that currently the company's products are not yet involved in biotechnology synthesis technology.
仟源医药(300254.SZ):目前公司产品暂未涉及生物合成技术
shanxi c&y pharmaceutical group (300254.SZ): Currently, the company's products have not yet involved biotechnology.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.